References
- Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2012;64:206–212.10.1016/j.addr.2012.09.033
- Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discovery. 2008;7:771–782.10.1038/nrd2614
- Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J. Control. Release. 2010;145:182–195.10.1016/j.jconrel.2010.01.036
- Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacol. Res. 2010;62:90–99.10.1016/j.phrs.2010.03.005
- Sultana S, Khan MR, Kumar M, et al. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review. J. Drug Target. 2013;21:107–125.10.3109/1061186X.2012.712130
- Xu S, Olenyuk BZ, Okamoto CT, et al. Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv. Drug Deliv. Rev. 2013;65:121–138.10.1016/j.addr.2012.09.041
- Yameen B, Choi WI, Vilos C, et al. Insight into nanoparticle cellular uptake and intracellular targeting. J. Control. Release. 2014;190:485–499.10.1016/j.jconrel.2014.06.038
- Marin JJG, Macias RIR, Briz O, et al. Bile acids in physiology, Pathology and Pharmacology. Curr. Drug Metab. 2016;17:4–29.
- Sievanen E. Exploitation of bile acid transport systems in prodrug design. Molecules. 2007;12:1859–1889.10.3390/12081859
- Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm. Res. 2007;24:1803–1823.10.1007/s11095-007-9289-1
- Kullak-Ublick GA, Stieger B, Hagenbuch B, et al. Hepatic transport of bile salts. Semin. Liver Dis. 2000;20:273–292.10.1055/s-2000-9426
- Enhsen A, Kramer W, Wess G. Bile acids in drug discovery. Drug Discov. Today. 1998;3:409–418.10.1016/S1359-6446(96)10046-5
- Vivian D, Polli JE. Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver. Int. J. Pharm. 2014;475:597–604.10.1016/j.ijpharm.2014.09.014
- Zhu XX, Nichifor M. Polymeric materials containing bile acids. Acc. Chem. Res. 2002;35:539–546.10.1021/ar0101180
- Chen D-q, Wang X, Chen L, et al. Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: synthesis and biological characterization. Acta Pharmacol. Sin. 2011;32:664–672.
- Gautrot JE, Zhu XX. Biodegradable polymers based on bile acids and potential biomedical applications. J. Biomat. Sci. Polym. Ed. 2006;17:1123–1139.10.1163/156856206778530713
- Zeng X, Tao W, Mei L, et al. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials. 2013;34:6058–6067.10.1016/j.biomaterials.2013.04.052
- Tang X, Cai S, Zhang R, et al. Paclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatment. Nanoscale Res. Lett. 2013;8: 420–431.
- Patil YB, Toti US, Khdair A, et al. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials. 2009;30:859–866.10.1016/j.biomaterials.2008.09.056
- Xiao Y, Wiesner MR. Characterization of surface hydrophobicity of engineered nanoparticles. J. Hazard. Mater. 2012;215:146–151.10.1016/j.jhazmat.2012.02.043
- Iversen T-G, Skotland T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today. 2011;6:176–185.10.1016/j.nantod.2011.02.003
- Pho MT, Ashok A, Atwood WJ. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 2000;74:2288–2292.10.1128/JVI.74.5.2288-2292.2000
- Hillaireau H, Couvreur P. Nanocarriers’ entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 2009;66:2873–2896.10.1007/s00018-009-0053-z
- Wang L-H, Rothberg KG, Richard GWA. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 1993;123:1107–1117.10.1083/jcb.123.5.1107
- Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J. Cell Biol. 1998;141:905–915.10.1083/jcb.141.4.905
- Kanlaya R, Sintiprungrat K, Chaiyarit S, et al. Macropinocytosis is the major mechanism for endocytosis of calcium oxalate crystals into renal tubular cells. Cell Biochem. Biophys. 2013;67:1171–1179.10.1007/s12013-013-9630-8
- Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu. Rev. Biochem. 2009;78:857–902.10.1146/annurev.biochem.78.081307.110540
- Lu YJ, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 2002;54:675–693.10.1016/S0169-409X(02)00042-X